News

In Northwest Biotherapeutics’s (NWBT) trial, the two patients who have received treatment attained eight months and six months without progression, respectively. Each of these NWBT patients had metastases

TPI 1100 is a inhaled inhibitor against phosphodiesterases (PDEs), PDE 4 and PDE 7. PDEs are a group of enzymes that are validated targets for chronic obstructive pulmonary

AstraZeneca is evaluating the contents of the complete response letter (CRL) and the proposed labeling revisions. AstraZeneca will continue discussions with the FDA and will provide a response

The drug candidate is currently in a Phase I/II clinical trial for the treatment of recurrent malignant melanoma. The company had previously received orphan designation for 131I-TM601 in

The relationship between the Hubbard and Harrington health systems has the potential to collaborate in ventures designed in the best interest of their patients, said Harrington Hospital. Chris

Final approval of this product is expected upon resolution of patent litigation. According to Teva, the brand product had annual sales of approximately $3.8 billion in the US

Under the terms of the definitive agreement, Thermage purchased Reliant for approximately $25 million in cash, 23.6 million shares of Thermage common stock, and the assumption of up

Mr Yockstick has broad management experience in executive and leadership positions across a wide range of commercial, operational, and quality functions, as well as being a leader and

Most recently, Mr Fust was executive vice president and CFO at Jazz Pharmaceuticals, which he joined in 2003. From 2002 until 2003, he was CFO at Perlegen Sciences.